Beat Biotherapeutics, A U Washington Start-up, Raises $2.5M For Heart Failure Treatment
Beat Biotherapeutics looked like it was in trouble after its co-founder and CEO died suddenly in June 2009. But the University of Washington spinout is definitely back in business, after recruiting a veteran CEO and raising another $2.5 million to advance an experimental treatment for heart failure.